Thrombopoietin receptor agonists (TPO-RAs) are a class of drugs designed to mimic the activity of thrombopoietin, a natural hormone responsible for the production of platelets. These drugs are primarily used to treat conditions like thrombocytopenia, where the body has an abnormally low level of platelets, which is often a side effect of cancer treatments such as chemotherapy.
